Chemoinformaics analysis of Nomilin 17-beta-D-glucopyranoside
| Molecular Weight | 694.727 | nRot | 7 |
| Heavy Atom Molecular Weight | 648.359 | nRig | 35 |
| Exact Molecular Weight | 694.284 | nRing | 6 |
| Solubility: LogS | -3.464 | nHRing | 4 |
| Solubility: LogP | 1.793 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 95 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 49 | No. of Aromatic Carbocycles | 0 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 5 |
| nHA | 14 | APOL | 99.4825 |
| nHD | 4 | BPOL | 61.7715 |
| QED | 0.235 |
| Synth | 6.367 |
| Natural Product Likeliness | 2.582 |
| NR-PPAR-gamma | 0.038 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.526 |
| Pgp-sub | 0.973 |
| HIA | 0.863 |
| CACO-2 | -5.544 |
| MDCK | 0.0000485 |
| BBB | 0.074 |
| PPB | 0.743789 |
| VDSS | 0.438 |
| FU | 0.222725 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.109 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.204 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.026 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.067 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.065 |
| CL | 2.029 |
| T12 | 0.873 |
| hERG | 0.011 |
| Ames | 0.221 |
| ROA | 0.89 |
| SkinSen | 0.074 |
| Carcinogencity | 0.133 |
| EI | 0.018 |
| Respiratory | 0.911 |
| NR-Aromatase | 0.09 |
| Antiviral | Yes |
| Prediction | 0.899744 |